| Literature DB >> 28595995 |
Helen Hermann1, Toomas Runnel2, Alar Aab1, Hansjörg Baurecht3, Elke Rodriguez3, Nathaniel Magilnick4, Egon Urgard1, Liisi Šahmatova5, Ele Prans6, Julia Maslovskaja1, Kristi Abram7, Maire Karelson7, Bret Kaldvee5, Paula Reemann1, Uku Haljasorg1, Beate Rückert8, Paulina Wawrzyniak8, Michael Weichenthal3, Ulrich Mrowietz3, Andre Franke9, Christian Gieger10, Jonathan Barker11, Richard Trembath12, Lam C Tsoi13, James T Elder14, Eric R Tkaczyk15, Kai Kisand1, Pärt Peterson1, Külli Kingo5, Mark Boldin4, Stephan Weidinger3, Cezmi A Akdis8, Ana Rebane16.
Abstract
miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of skin inflammation. Little is known about the role of miR-146b in the skin. In this study, we confirmed the increased expression of miR-146a and miR-146b (miR-146a/b) in the lesional skin of patients with psoriasis. The expression of miR-146a was approximately twofold higher than that of miR-146b in healthy human skin, and it was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblasts. miR-146a/b target genes regulating inflammatory responses or proliferation were altered in the skin of patients with psoriasis, among which FERMT1 was verified as a direct target of miR-146a. In silico analysis of genome-wide data from >4,000 psoriasis cases and >8,000 controls confirmed a moderate association between psoriasis and genetic variants in the miR-146a encoding gene. Transfection of miR-146a/b suppressed and inhibition enhanced keratinocyte proliferation and the expression of psoriasis-related target genes. Enhanced expression of miR-146a/b-influenced genes was detected in cultured keratinocytes from miR-146a-/- and skin fibroblasts from miR-146a-/- and miR-146b-/- mice stimulated with psoriasis-associated cytokines as compared with wild-type mice. Our results indicate that besides miR-146a, miR-146b is expressed and might be capable of modulation of inflammatory responses and keratinocyte proliferation in psoriatic skin.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28595995 PMCID: PMC5977389 DOI: 10.1016/j.jid.2017.05.012
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551